Literature DB >> 8826089

Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro.

A R Severson1, R T Ingram, L A Fitzpatrick.   

Abstract

Atherosclerotic lesions are composed of cellular elements that have migrated from the vessel lumen and wall to form the cellular component of the developing plaque. The cellular elements are influenced by various growth-regulatory molecules, cytokines, chemoattractants, and vasoregulatory molecules that regulate the synthesis of the extracellular matrix composing the plaque. Because vascular smooth muscle cells (VSMC) constitute the major cellular elements of the atherosclerotic plaque and are thought to be responsible for the extracellular matrix that becomes calcified in mature plaques, immunostaining for collagenous and noncollagenous proteins typically associated with bone matrix was conducted on VSMC grown in vitro. VSMC obtained from human aorta were grown in chambers on glass slides and immunostained for procollagen type I, bone sialoprotein, osteonectin, osteocalcin, osteopontin, decorin, and biglycan. VSMC demonstrated an intense staining for procollagen type I, and a moderately intense staining for the noncollagenous proteins, bone sialoprotein and osteonectin, two proteins closely associated with bone mineralization. Minimal immunostaining was noted for osteocalcin, osteopontin, decorin, and biglycan. The presence in VSMC of collagenous and noncollagenous proteins associated with bone mineralization suggest that the smooth muscle cells in the developing atherosclerotic plaque play an important role in the deposition of the extracellular matrix involved in calcification of developing lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8826089     DOI: 10.1007/BF02634569

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  37 in total

1.  Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations.

Authors:  M C Burleigh; A D Briggs; C L Lendon; M J Davies; G V Born; P D Richardson
Journal:  Atherosclerosis       Date:  1992-09       Impact factor: 5.162

2.  Studies on the chemical composition of normal and abnormal blood vessel walls. I. Chemical nature of vascular calcified deposits.

Authors:  D CARLSTROM; B ENGFELDT; A ENGSTROM; N RINGERTZ
Journal:  Lab Invest       Date:  1953 Sep-Oct       Impact factor: 5.662

3.  Extracellular matrix-smooth muscle phenotype modulation by macrophages.

Authors:  J H Campbell; S G Kalevitch; R E Rennick; G R Campbell
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Collagen species in various sized human arteries and their changes with intimal proliferation.

Authors:  K Murata; T Motoyama
Journal:  Artery       Date:  1990

5.  Characterization of extracellular matrix proteoglycan transcripts expressed by vascular smooth muscle cells.

Authors:  V Asundi; K Cowan; D Matzura; W Wagner; K L Dreher
Journal:  Eur J Cell Biol       Date:  1990-06       Impact factor: 4.492

6.  Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity.

Authors:  R T Ingram; B L Clarke; L W Fisher; L A Fitzpatrick
Journal:  J Bone Miner Res       Date:  1993-09       Impact factor: 6.741

7.  Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta.

Authors:  T Ikeda; T Shirasawa; Y Esaki; S Yoshiki; K Hirokawa
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Resorption of implanted bone prepared from normal and warfarin-treated rats.

Authors:  J B Lian; M Tassinari; J Glowacki
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix.

Authors:  P Bianco; M Riminucci; G Silvestrini; E Bonucci; J D Termine; L W Fisher; P G Robey
Journal:  J Histochem Cytochem       Date:  1993-02       Impact factor: 2.479

10.  Production of transforming growth factor beta 1 during repair of arterial injury.

Authors:  M W Majesky; V Lindner; D R Twardzik; S M Schwartz; M A Reidy
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more
  6 in total

1.  Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves.

Authors:  S S Srivatsa; P J Harrity; P B Maercklein; L Kleppe; J Veinot; W D Edwards; C M Johnson; L A Fitzpatrick
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  High-resolution MR study of the relationship between superficial calcification and the stability of carotid atherosclerotic plaque.

Authors:  Xian Xu; Haiyue Ju; Jianming Cai; Youquan Cai; Xinjiang Wang; Qingjun Wang
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-06       Impact factor: 2.357

Review 3.  Coronary arterial calcification as an active process: a new perspective on an old problem.

Authors:  T M Doherty; R C Detrano
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

Review 4.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

Review 5.  Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review).

Authors:  Lianpu Wen; Jiepeng Chen; Lili Duan; Shuzhuang Li
Journal:  Mol Med Rep       Date:  2018-04-27       Impact factor: 2.952

Review 6.  Potential Role for Osteocalcin in the Development of Atherosclerosis and Blood Vessel Disease.

Authors:  Alexander Tacey; Tawar Qaradakhi; Tara Brennan-Speranza; Alan Hayes; Anthony Zulli; Itamar Levinger
Journal:  Nutrients       Date:  2018-10-04       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.